METHYLPHENIDATE HYDROCHLORIDE tablet, chewable ארצות הברית - אנגלית - NLM (National Library of Medicine)

methylphenidate hydrochloride tablet, chewable

lupin pharmaceuticals,inc. - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 2.5 mg - attention deficit disorders , narcolepsy attention deficit disorders (previously known as minimal brain dysfunction in children). other terms being used to describe the behavioral syndrome below include: hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction. methylphenidate hydrochloride chewable tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. specific etiology of this syndrome is unknown, and there is no single diagnostic test. adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. characteristics commonly reported include: chronic history of short attention span, distractibility, emotional lability, impulsivity, and moderate-to-severe hyperactivity; minor neurological signs and abnormal eeg. learning may or may not be impaired. the diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of one or more of these characteristics. drug treatment is not indicated for all children with this syndrome. stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and/or primary psychiatric disorders, including psychosis. appropriate educational placement is essential and psychosocial intervention is generally necessary. when remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms. methylphenidate hydrochloride chewable tablet is contraindicated in patients known to be hypersensitive to methylphenidate or other components of the drug. methylphenidate hydrochloride chewable tablets are contraindicated during treatment with monoamine oxidase inhibitors, and also within a minimum of 14 days following discontinuation of a monoamine oxidase inhibitor (hypertensive crises may result).

CONCERTA methylphenidate hydrochloride 27mg modified release tablet bottle אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

concerta methylphenidate hydrochloride 27mg modified release tablet bottle

janssen-cilag pty ltd - methylphenidate hydrochloride, quantity: 27 mg - tablet, modified release - excipient ingredients: cellulose acetate; polyethylene oxide; butylated hydroxytoluene; stearic acid; succinic acid; iron oxide red; poloxamer; carnauba wax; hypromellose; sodium chloride; phosphoric acid; povidone; iron oxide yellow; iron oxide black; titanium dioxide; lactose monohydrate; triacetin; macrogol 400; propylene glycol; isopropyl alcohol; purified water - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd). treatment should be commenced by a specialist.,a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years.,need for comprehensive treatment programme concerta is indicated as an integral part of a total treatment program for adhd that may include other measures (psychological, educational and social) for patients with this syndrome. stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. appropriate educational placement is essential and psychosocial intervention is often helpful. when remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician?s assessment of the chronicity and severity of the patient?s symptoms.,long term use the effectiveness of concerta for long-term use has not been systematically evaluated in controlled trials. therefore the physician who elects to use concerta for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

CIRCOPOWER ACID/SANITISER LIQUID CLEANER/SANITISER FOR MILKING AND MILK COOLING INSTALLATIONS אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

circopower acid/sanitiser liquid cleaner/sanitiser for milking and milk cooling installations

gea westfaliasurge australia pty ltd - phosphoric acid | benzalkonium chloride - dairy cleanser - milk plant | milk vat | bulk milk vat | dairy processing applications - milkstone removal | sanitiser | milk fat | milk protein | mineral deposits

SILO LIQUID ACID DAIRY DETERGENT & SANITISER אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

silo liquid acid dairy detergent & sanitiser

chemical formulators pty ltd - phosphoric acid | benzalkonium chloride - dairy cleanser - milk vat | milking equipment | stored product facilities | bulk milk vat | empty silo | farm machinery | machinery | milking mac - bacterial prevention, cleansing or disin | sanitiser | disinfecting

B13 CELL SALT COMPLEX- allium sativum, avena sativa, calcarea carbonica, calcarea fluorica, calcarea phosphorica, calcarea sulphurica, carbo vegetabilis, ferrum iodatum, hypericum perforatum, kali phosphoricum, lacticum acidum, magnesia phosphorica, natrum muriaticum, natrum phosphoricum, phosphoricum acidum, urtica urens solution/ drops ארצות הברית - אנגלית - NLM (National Library of Medicine)

b13 cell salt complex- allium sativum, avena sativa, calcarea carbonica, calcarea fluorica, calcarea phosphorica, calcarea sulphurica, carbo vegetabilis, ferrum iodatum, hypericum perforatum, kali phosphoricum, lacticum acidum, magnesia phosphorica, natrum muriaticum, natrum phosphoricum, phosphoricum acidum, urtica urens solution/ drops

apex energetics inc. - potassium phosphate, dibasic (unii: ci71s98n1z) (potassium cation - unii:295o53k152), garlic (unii: v1v998dc17) (garlic - unii:v1v998dc17), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), magnesium phosphate, dibasic trihydrate (unii: hf539g9l3q) (magnesium cation - unii:t6v3lhy838), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), tribasic calcium phosphate (unii: 91d9gv0z28) (phosphate ion - unii:nk08v8k8hr), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic, heptahydrate (unii: 70wt22sf4b) (sodium cation - unii:lyr4m0nh37), calcium sulfate anhydrous (unii: e934b3v59h) (calcium cation - unii:2m83c4r6zb), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), hypericum perforatum (unii: xk4iux8mnb) (hypericum perforatum - unii:xk4iux8mnb), lactic acid, dl- (unii: 3b8d35y7s4) (lactic acid, dl- - unii:3b8d35y7s4), ferrous iodide (unii: f5452u54pn) (ferrous iodide - unii:f5452u54pn), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), urtica urens (unii: ihn2nq5of9) (urtica urens - unii:ihn2nq5of9) - for temporary relief of minor: fatigue* exhaustion* nervous irritability* muscle cramps* dizziness* * claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

PHOSPHORICUM ACIDUM- orthophosphoric acid granule ארצות הברית - אנגלית - NLM (National Library of Medicine)

phosphoricum acidum- orthophosphoric acid granule

seroyal usa - phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn) - phosphoric acid 3 [hp_x] - indications for the temporary relief of mental and physical exhaustion indications for the temporary relief of mental and physical exhaustion directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.

ACIDQUAT ACID MILKING MACHINE DETERGENT אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

acidquat acid milking machine detergent

delaval pty ltd - phosphoric acid 81% | benzalkonium chloride - dairy cleanser - milking equipment | milking machine - milkstone removal | milk fat | milk protein | mineral deposits

ACID-KLENZ ACID DAIRY DETERGENT FOR MILKSTONE REMOVAL אוסטרליה - אנגלית - APVMA (Australian Pesticides and Veterinary Medicines Authority)

acid-klenz acid dairy detergent for milkstone removal

dasco proprietary limited - phosphoric acid; n-alkyl dimethyl benzyl ammonium chloride - aqueous concentrate - phosphoric acid mineral-phosphorus-acid active 500.0 g/l; n-alkyl dimethyl benzyl ammonium chloride ammonium active 25.0 g/l - dairy cleanser - dairy plant stainless steel | building - milkstone removal | milk fat | milk protein | mineral deposits

AC QUAT NR LIQUID קנדה - אנגלית - Health Canada

ac quat nr liquid

constant international inc - didecyl dimethyl ammonium chloride; benzalkonium chloride; phosphoric acid; dioctyl dimethyl ammonium chloride; octyl decyl dimethyl ammonium chloride - liquid - 1.37664%; 3.0592%; 30.0%; 0.91776%; 2.2944% - didecyl dimethyl ammonium chloride 1.37664%; benzalkonium chloride 3.0592%; phosphoric acid 30.0%; dioctyl dimethyl ammonium chloride 0.91776%; octyl decyl dimethyl ammonium chloride 2.2944% - disinfectants (for agents used on object)